News & Updates

Show Multimedia Only

Topical plant-based drug induces durable hair growth in children with moderate to severe AA

24 Oct 2023 by

Twice-daily application of the botanical coacillium 22.25% cutaneous solution leads to significant hair growth in children and adolescents with moderate-to-severe alopecia areata (AA), with the improvement in hair loss sustained through months after treatment discontinuation, according to data from the phase II/III RAAINBOW trial.

24 Oct 2023

COVID shots hold up against Omicron XBB for youngest kids in SG

23 Oct 2023 by

The monovalent mRNA vaccine helped stave off severe COVID-19 outcomes in children aged 1 to 4 years during the Omicron wave, as shown in a study from Singapore.

23 Oct 2023

BP control, antihypertensive drug use prevent death after stroke

23 Oct 2023

Ischaemic stroke (IS) patients with consistently controlled blood pressure (BP) and who regularly take antihypertensive medications following discharge have lower risks of death and vascular events, reports a recent study.

23 Oct 2023

Aztreonam-avibactam cures serious infections due to Gram-negative bacteria

23 Oct 2023 by

Treatment with aztreonam in combination with avibactam (ATM-AVI) results in favourable clinical response and is well tolerated in patients with complicated intra-abdominal infection (cIAI) and hospital-acquired or ventilator-associated pneumonia (HAP/VAP) due to Gram-negative bacteria, according to the results of the REVISIT study.

23 Oct 2023

Dalbavancin an effective treatment option for serious gram-positive infections

23 Oct 2023 by

In a real-world study presented at IDWeek 2023, dalbavancin has been shown to be an effective treatment alternative for patients with invasive gram-positive infections.

23 Oct 2023

Small wins for amlitelimab in STREAM-AD

23 Oct 2023 by

The experimental drug amlitelimab has scored positive outcomes in the double-blind, placebo-controlled phase IIb STREAM-AD study evaluating it as a treatment for moderate-to-severe atopic dermatitis (AD).

23 Oct 2023

Obeticholic acid shows therapeutic potential in LPAC syndrome

22 Oct 2023

The selective farnesoid-X receptor agonist obeticholic acid appears to improve symptoms of low phospholipid-associated cholelithiasis (LPAC) syndrome in patients who have inadequate response or intolerance to ursodeoxycholic acid, as shown in a small study.

22 Oct 2023

Do alpha-1 receptor blockers help prevent COVID-19 hospitalization?

22 Oct 2023

Frequent use of alpha-1 receptor blockers is neither harmful nor protective against the risk of uncomplicated or severe COVID-19 hospitalization, a study has shown.

22 Oct 2023

Nonsteroidal cream brings early relief in atopic dermatitis itch

21 Oct 2023 by

In children and adults with moderate-to-severe atopic dermatitis, applying tapinarof cream 1% helps reduce itch within 24 hours, according to the results of the phase III trials ADORING 1 and 2.

21 Oct 2023

$Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma$

Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma

20 Oct 2023

The multikinase inhibitor anlotinib appears to have promising antitumour activity in the treatment of locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma while having an acceptable safety profile, as shown in a phase II study.

20 Oct 2023

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Topical plant-based drug induces durable hair growth in children with moderate to severe AA

COVID shots hold up against Omicron XBB for youngest kids in SG

BP control, antihypertensive drug use prevent death after stroke

Aztreonam-avibactam cures serious infections due to Gram-negative bacteria

Dalbavancin an effective treatment option for serious gram-positive infections

Small wins for amlitelimab in STREAM-AD

Obeticholic acid shows therapeutic potential in LPAC syndrome

Do alpha-1 receptor blockers help prevent COVID-19 hospitalization?

Nonsteroidal cream brings early relief in atopic dermatitis itch

Anlotinib shows promise for radioiodine-refractory differentiated thyroid carcinoma